Chronic antepartum maternal hyperoxygenation in a case of severe fetal Ebstein's anomaly with circular shunt

Alisa Arunamata1, David M Axelrod1, Katherine Bianco2

  • 1Department of Pediatrics, Division of Pediatric Cardiology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.

Insights

Maternal oxygen therapy may help fetuses with Ebstein

Area of Science:

  • Cardiology
  • Fetal Medicine
  • Neonatal Care

Background:

  • Ebstein's anomaly of the tricuspid valve is associated with high perinatal mortality.
  • Pulmonary valve regurgitation in fetuses with Ebstein's anomaly poses a particularly high risk.
  • Circular shunt physiology and systemic steal are critical concerns in these cases.

Observation:

  • A late-presenting case of Ebstein's anomaly with severe tricuspid regurgitation was observed.
  • The fetus exhibited continuous pulmonary valve regurgitation and reversed ductal flow.
  • Chronic antepartum maternal oxygen therapy was administered.

Findings:

  • Maternal oxygen therapy led to fetal ductus arteriosus constriction.
  • This intervention modulated fetal pulmonary vascular resistance.
  • The strategy aimed to mitigate systemic steal in a complex cardiac defect.

Implications:

  • Antepartum maternal oxygen therapy may be a novel strategy for managing fetal Ebstein's anomaly with pulmonary valve regurgitation.
  • This approach could offer a new pathway to reduce perinatal mortality in high-risk fetal cardiac conditions.
  • Further research is warranted to validate this therapeutic option in perinatal cardiology.

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
3.5K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
7.3K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
976
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
671